MAPT and early-onset autosomal dominant Alzheimer disease: This study is conducted in a well-characterized Alzheimer’s disease research cohort with high-affinity PET imaging agents for Aβ plaques and tau neurofibrillary tangles, yet several limitations need to be noted.